Yogesh Jethava, MD
Hematology · Park Ridge, ILNPI 1841622701
Payments from drug & device makers
Across 572 payments — averaging $2517.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$433K
- Novartis$243K
- AbbVie$136K
- ADC Therapeutics America, Inc.$96K
- Johnson & Johnson$89K
- Beigene USA, Inc.$87K
- plus $356K from 28 others
Across 11 payments — averaging $812.73 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$9K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 50 | $432,674 |
| Novartis | 9 | $243,079 |
| AbbVie | 19 | $135,877 |
| ADC Therapeutics America, Inc. | 49 | $96,007 |
| Johnson & Johnson | 66 | $89,037 |
| Beigene USA, Inc. | 55 | $87,130 |
| Karyopharm Therapeutics Inc. | 35 | $67,489 |
| Sanofi | 33 | $56,446 |
| Incyte Corporation | 74 | $48,231 |
| Seagen Inc. | 7 | $47,267 |
| E.r. Squibb & Sons, L.L.C. | 24 | $34,559 |
| Janssen Research & Development, LLC | 17 | $19,943 |
| Syndax Pharmaceuticals, Inc. | 18 | $17,754 |
| Bristol Myers Squibb | 26 | $17,519 |
| Genmab U.S., Inc. | 17 | $16,692 |
| Amgen | 10 | $7,456 |
| Morphosys, US Inc. | 6 | $6,374 |
| Lilly USA, LLC | 2 | $4,063 |
| TG Therapeutics, Inc. | 2 | $3,485 |
| Adaptive Biotechnologies Corporation | 7 | $3,322 |
| GSK | 22 | $2,640 |
| Partner Therapeutics, Inc. | 3 | $1,704 |
| Janssen Scientific Affairs, LLC | 3 | $160 |
| Jazz Pharmaceuticals Inc. | 2 | $157 |
| Autolus Inc | 2 | $153 |
| Epizyme, Inc. | 1 | $125 |
| Legend Biotech USA Inc. | 6 | $122 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $107 |
| Cardinal Health 110 LLC | 1 | $89 |
| Sanofi-aventis U.S. LLC | 1 | $33 |
| Gilead | 1 | $23 |
| Stemline Therapeutics Inc. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Astellas Pharma US Inc | 1 | $13 |
How this compares
$1,439,765 in reported general payments places this provider in the 85th percentile of 49 hematology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology in Park Ridge
- Deborah KatzChicago$3.3M
- John QuigleyChicago$3.3M
- Seema SinghalChicago$2.5M
- Victoria ShusharinaTinley Park$2.5M
- Nadia KhanChicago$2.2M
- Olga FrankfurtChicago$1.4M
- Seo-Hyun KimChicago$1.1M
- David GrinblattEvanston$1.1M
- Parameswa VenugopalChicago$896K
- Stephanie TsaiMaywood$767K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.